BenzingaNovember 9, 2026 at 3:36 AM NYYesterday
Tango Therapeutics Q3 EPS $(0.39) Misses $(0.35) Estimate
Tango Therapeutics (NASDAQ:TNGX) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $(0.35) by 11.43 percent. This is a 378.57 percent decrease over earnings of $0.14 per share
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
